Flu Vaccine Potency Remains Top Of Mind As US Panel Prepares To Pick Next Season's Strains

FDA advisory committee will vote on WHO's flu strain recommendations as agency hunts for root causes of low effectiveness of current season’s vaccine. 

Vaccination

More from US FDA Performance Tracker

More from Regulatory Trackers